Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bausch + Lomb Corporation Common Shares
(NY:
BLCO
)
16.91
-0.24 (-1.43%)
Streaming Delayed Price
Updated: 1:03 PM EST, Feb 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bausch + Lomb Corporation Common Shares
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Bausch + Lomb Acquires AcuFocus, Inc.
January 17, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™
January 09, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Publishes Update Presentation for the 41st Annual J.P. Morgan Healthcare Conference
January 09, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
7 Analysts Have This to Say About Bausch & Lomb
↗
December 21, 2022
Via
Benzinga
What 7 Analyst Ratings Have To Say About Bausch & Lomb
↗
November 23, 2022
Via
Benzinga
Expert Ratings for Bausch & Lomb
↗
November 03, 2022
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter:
Via
Benzinga
What 4 Analyst Ratings Have To Say About Bausch & Lomb
↗
October 11, 2022
Analysts have provided the following ratings for Bausch & Lomb (NYSE:BLCO) within the last quarter:
Via
Benzinga
Bausch + Lomb Announces Participation at the 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in Ophthalmology
January 04, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb and Glaucoma Research Foundation Announce Launch of Screen, Protect, Cure Campaign In Recognition of Glaucoma Awareness Month
January 03, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
What 4 Analyst Ratings Have To Say About Bausch & Lomb
↗
September 12, 2022
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Expert Ratings for Bausch & Lomb
↗
September 12, 2022
Within the last quarter, Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
↗
December 21, 2022
Via
Benzinga
Battered FTX's CEO Sam Bankman-Fried Arrested, Elon Musk's SpaceX Mammoth Valuation Of $140B, China Weighs Over $143B In Semiconductor Push: Top Stories Tuesday, Dec. 13
↗
December 13, 2022
Benzinga Sam Bankman-Fried Arrested In The Bahamas
Via
Benzinga
Expert Ratings for Bausch & Lomb
↗
August 16, 2022
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter:
Via
Benzinga
'Well-Established' Eye Health Company Bausch + Lomb Gets Outperform Rating From This Analyst
↗
July 26, 2022
Via
Benzinga
Bausch Health Investors Request Blocking Eye-Care Business Spinoff, Alleging Protection From Lawsuits
↗
December 13, 2022
More than 50 funds that own Bausch Health Companies Inc (NYSE: BHC) investors are reportedly seeking to block the eye-care business spin-off, Bausch + Lomb Corp (NYSE: BLCO).
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2022
↗
September 12, 2022
Upgrades
Via
Benzinga
From Corporate Raider To Activist Investor: Here Are Three High-Yielding Stocks Carl Icahn Favors
↗
August 28, 2022
Formerly known as a "corporate raider," Carl Icahn is the founder and controlling shareholder of Icahn Enterprises, which is a large holding company with well diversified positions.
Via
Benzinga
Expert Ratings for Bausch & Lomb
↗
July 26, 2022
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter:
Via
Benzinga
IPO Market Posts Slowest Quarter Since Great Recession
↗
June 24, 2022
IPOs in the second quarter plunged to the lowest level since the Great Recession in 2009, led by health care and technology.
Via
Investor's Business Daily
BHC Stock Continues to Fall as Bausch Health Responds to Court Decision
↗
July 29, 2022
Although Bausch Health promises to fight back against an unfavorable patent protection ruling, BHC stock is still hurting.
Via
InvestorPlace
Bausch Health (BHC) Stock Plunges 50% on Patent News
↗
July 28, 2022
With Bausch Health losing a critical patent battle enabling its key drug to suffer generic competition, BHC stock veritably crumbled.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
↗
July 28, 2022
On Thursday, 108 companies set new 52-week lows.
Via
Benzinga
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
↗
July 28, 2022
Gainers
Via
Benzinga
Meta, Charter Communications, Southwest Airlines And Some Other Big Stocks Moving Lower On Thursday
↗
July 28, 2022
Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022
↗
July 26, 2022
Upgrades
Via
Benzinga
7 Ways to Prepare for a Recession: An Investor’s Guide
↗
June 24, 2022
There are plenty of ways to prepare for a recession. Here are seven ways you can make sure you're ready for whatever comes next.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022
↗
June 24, 2022
Upgrades
Via
Benzinga
2 Cheap Stocks Trading at “Deal of the Century” Prices
↗
June 10, 2022
Simple value metrics are provenly bad at generating consistent returns, but that doesn't mean there aren't opportunities to be found.
Via
InvestorPlace
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today